购物车
全部删除
您的购物车当前为空
别名 索拉珠单抗, LY2062430, LY 2062430
Solanezumab (LY 2062430) 是一种优先结合可溶性淀粉样蛋白的单克隆抗体,可促进其从大脑中清除。Solanezumab 可用于研究阿尔茨海默症。

为众多的药物研发团队赋能,
让新药发现更简单!
Solanezumab (LY 2062430) 是一种优先结合可溶性淀粉样蛋白的单克隆抗体,可促进其从大脑中清除。Solanezumab 可用于研究阿尔茨海默症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | 现货 | |
| 5 mg | ¥ 5,860 | 现货 | |
| 10 mg | ¥ 7,890 | 现货 | |
| 25 mg | ¥ 11,700 | 现货 | |
| 50 mg | ¥ 15,800 | 现货 |
Solanezumab 相关产品
| 产品描述 | Solanezumab (LY 2062430) is a monoclonal antibody that binds preferentially to soluble amyloid and promotes its clearance from the brain.Solanezumab is used in the study of Alzheimer's disease. |
| 别名 | 索拉珠单抗, LY2062430, LY 2062430 |
| 交叉反应 | Human |
| 应用 | ELISA FACS Functional assay |
| 抗体种类 | Monoclonal |
| 宿主来源 | < 1.0 EU/mg |
| 偶联 | Unconjugated |
| Uniprot ID |
| 分子量 | 144.1 (kDa) |
| CAS No. | 955085-14-0 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容